Table 1.
Group A | Group B | P value | |
---|---|---|---|
No. of patients | 21 | 33 | — |
No. of treatment cycles | 21 | 33 | — |
No. of long protocols (%) | 16 (76) | 24 (73) | — |
No. of antagonist protocols (%) | 5 (24) | 9 (27) | — |
Age (y) | 35.6 ± 3.0 | 34.1 ± 3.9 | 0.12 |
AMH (ng/mL) | 4.78 ± 2.49 | 4.69 ± 2.29 | 0.91 |
BMI | 21.5 ± 2.3 | 21.0 ± 2.7 | 0.51 |
No. of retrieved oocytes per cycle | 12.8 ± 7.0 | 12.1 ± 6.3 | 0.68 |
No. of retrieved oocytes per cycle in long protocols | 12.1 ± 6.4 | 10.9 ± 5.5 | 0.51 |
No. of retrieved oocytes per cycle in antagonist protocols | 14.8 ± 9.0 | 15.1 ± 7.4 | 0.95 |
Period retrieval to ICSI (min) | 257.2 ± 53.7 | 263.6 ± 44.4 | 0.63 |
AMH, anti‐Mullerian hormone; BMI, body mass index